Home > Insider Trading > Charming Shoppes Inc

Charming Shoppes Inc (CHRS)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

1 - 10
Next >>

Coherus BioSciences, Inc. (NASDAQ:CHRS) Q3 2024 Earnings Call Transcript

Operator: Good day, and thank you for standing by. Welcome to the Q3 2024 Coherus BioSciences Earnings Conference Call. At this time, all participants are in a listen-only mode.

Keep Reading →

November 8th, 2024 - News Transcripts

15 Worst 52-Week Low Stocks to Buy Now According to Short Sellers

The U.S. Federal Reserve conducting a 50 basis point interest rate cut was the catalyst that stocks needed to bounce back from a period of stagnation.

Keep Reading →

September 24th, 2024 - Hedge Funds News

Coherus BioSciences, Inc. (NASDAQ:CHRS) Q1 2024 Earnings Call Transcript

Coherus BioSciences, Inc. (NASDAQ:CHRS) Q1 2024 Earnings Call Transcript May 10, 2024.

Keep Reading →

May 10th, 2024 - News Transcripts

Coherus BioSciences, Inc. (NASDAQ:CHRS) Q4 2023 Earnings Call Transcript

Coherus BioSciences, Inc. misses on earnings expectations. Reported EPS is $-0.62 EPS, expectations were $-0.21.

Keep Reading →

March 16th, 2024 - News Transcripts

Here’s Why Aristotle Small Cap Equity Strategy Sold Coherus BioSciences (CHRS)

Aristotle Capital Boston, LLC, an investment advisor, released its “Small Cap Equity Strategy” fourth quarter 2023 investor letter. A copy of the same can be downloaded here.

Keep Reading →

January 12th, 2024 - Hedge Fund Investor Letters News

Coherus BioSciences, Inc. (NASDAQ:CHRS) Q3 2023 Earnings Call Transcript

Operator: Good day and thank you for standing by. Welcome to the Coherus Biosciences Third Quarter 2023 Conference Call. At this time all participants are in a listen-only mode.

Keep Reading →

November 7th, 2023 - News Transcripts

Coherus BioSciences, Inc. (NASDAQ:CHRS) Q2 2023 Earnings Call Transcript

Operator: Good day and thank you for standing by. Welcome to the Coherus Biosciences Second Quarter 2023 Conference Call. At this time all participants are in a listen-only mode.

Keep Reading →

August 4th, 2023 - News Transcripts

Coherus BioSciences, Inc. (NASDAQ:CHRS) Q1 2023 Earnings Call Transcript

Operator: Good day and thank you for standing by. Welcome to the Coherus Biosciences Q1 2023 Earnings Call. Please be advised that today’s conference is being recorded.

Keep Reading →

May 10th, 2023 - News Transcripts

Coherus BioSciences, Inc. (NASDAQ:CHRS) Q4 2022 Earnings Call Transcript

Operator: Thank you for standing by, and welcome to Coherus Biosciences Fourth Quarter and Fiscal Year 2022 Earnings Conference Call.

Keep Reading →

March 8th, 2023 - News Transcripts

Should You Invest in Coherus BioSciences (CHRS)?

Scout Investments, an affiliate of Carillon Tower Advisers, an investment management company, released its “Carillon Scout Small Cap Fund” third quarter 2022 investor letter.

Keep Reading →

January 3rd, 2023 - Hedge Fund Investor Letters News